---
title: 'Associate Director, Financial Planning & Analysis (Development Finance Business Partner) at Bicara Therapeutics'
canonical: 'https://feeny.ai/job/associate-director-financial-planning-analysis-development-finance-business-nt8nz0xbxns1'
type: 'job'
last_seen: '2026-09-06'
---

# Associate Director, Financial Planning & Analysis (Development Finance Business Partner) at Bicara Therapeutics

- **Company:** Bicara Therapeutics
- **Location:** Boston, MA
- **Employment:** part-time
- **Work type:** hybrid
- **Posted:** 2026-07-29
- **Last confirmed live:** 2026-09-06
- **Apply:** https://jobs.ashbyhq.com/bicara-therapeutics/1729f4c9-4306-46c3-b4da-a745fa52b19f

## Job description

## POSITION OVERVIEW

Bicara Therapeutics is seeking an Associate Director of FP&A for Development who will provide critical financial support to R&D pipeline activities and global manufacturing/CMC/supply chain operations from new study planning through product development phase, product launch and ongoing lifecycle management activities. This role will also be responsible for financial consolidation and report generation inclusive of both internal and external spend. It requires partnering with Development leadership to drive long-range planning, budgeting and spend tracking, clinical trial forecasting and cost of goods manufactured analysis.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

## RESPONSIBILITIES

Financial Business Partner for Development (Clinical Operations, Technical Operations, Supply Chain, Quality, Regulatory & Program Management)

- Partner with functional leaders to manage financial processes, including annual budgeting, long-range planning and forecast projections.
- Support timely analytics and reporting to drive budget accuracy/accountability and identify key drivers of variances to budget, highlighting potential risks and opportunities to estimates.
- Build and monitor Key Performance Indicators (KPIs) that predict outcomes, identify risks early, and unlock investment opportunities across the pipeline.
- Ensure consistency between functional planning assumptions and financial projections.
- Translate complex clinical & manufacturing/supply chain concepts and related financial impact (ie. forward-looking inventory build) to senior management level narratives.
- Monitor operating results across vendor sites and support potential cost control initiatives.
- Partner with Clinical Operations and R&D leaders to manage the financial lifecycle of clinical trials, including trial forecasting, enrollment-based modeling, and site-level cost analysis.
- Enable efficient and effective clinical portfolio management via robust business partnering by conducting scenario planning and evaluating trial vendor contracts.
- Help drive enterprise-wide manufacturing & optimized supply chain decision-making by providing financial analysis and modeling to evaluate strategic alternatives and Cost of Goods for Clinical and Commercial opportunities.
- Support Commercial launch planning initiatives and subsequent lifecycle management.
- Ad hoc financial analysis and dynamic, strategic modeling to support decision-making, scenario planning & strategic projects.

Financial consolidation & planning system operations

- Manage the budget/forecast consolidation process in the planning & analysis software (Adaptive Planning – Workday).
- Assist with system maintenance – incorporate changes to Chart Of Accounts and other dimension infrastructure.
- Identify and implement opportunities to streamline and automate reporting (ie. leverage system-generated dashboard reporting).
- Determine areas to create efficiencies in planning processes.

## QUALIFICATIONS

- BS in Finance/Accounting.
- 6+ years of relevant experience with at least 2+ years as a finance business partner.
- Prior experience in the biotech/life sciences industry with familiarity with product development stages.
- In-depth knowledge of clinical (CRO) and external manufacturing/CMC/supply chain in biotech/life sciences environment.
- Strong financial modeling & reporting experience.
- Demonstrated experience as a collaborative and effective business partner working with senior leaders.
- Ability to distill complex operational and financial topics to management-level narratives.
- Strong attention to detail and ability to effectively communicate financial concepts to operational team members.
- Team player who will offer optimal solutions to intricate issues.
- Can work individually, within a multi-disciplinary team and with external partners/vendors.
- Ability to shift priorities rapidly in dynamic biotech environment.
- Experience with financial planning software (e.g. Adaptive Planning).
- Expert in Excel, Word and PowerPoint.
- Alignment with Bicara's core values.

## COMPANY OVERVIEW

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com http://www.bicara.com.

Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

## About Bicara Therapeutics

## Company Overview
- **One-liner**: Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class bifunctional antibodies that combine tumor-targeting with tumor microenvironment modulation, with a lead asset in head and neck squamous cell carcinoma.
- **Entity Type**: Public (NASDAQ: BCAX)
- **Headquarters**: Boston, Massachusetts, USA
- **Founded**: 2020
- **Founders**: Not publicly listed

## Core Business
- **Industry**: Biotechnology – oncology drug development
- **Target Customers**: B2B (pharma partnerships, licensing) and ultimately cancer patients and healthcare providers
- **Mission**: "Dedicated to improving the lives of people living with cancer through the development of innovative targeted therapies… bringing hope and control back into their lives." [bicara.com](https://www.bicara.com/)

## Products & Services
- **[Ficerafusp alfa (BCA101)](https://www.bicara.com/)**: First-in-class, dual-action bifunctional antibody targeting EGFR and containing a TGF-β ligand trap. Currently in Phase 1/1b clinical development for HPV-negative head and neck squamous cell carcinoma and other solid tumors. Mechanism designed to deliver an immunomodulatory payload directly to the tumor microenvironment, reduce fibrosis/immunosuppression, and enable immune cell penetration. (Biologic, clinical-stage therapeutic)

## Market Standing
- **Valuation/Market Cap**: ~$1.3 billion (as of mid-2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Key Metric**: Total funding raised $825M (includes Series C $165M led by The Rise Fund and TPG, $362M from 2024 IPO, and a $150M post-IPO equity round in February 2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Notable Investors/Partners**: The Rise Fund, TPG, Biocon (seed round). Additional institutional investors from IPO and follow-on offerings.
- **Growth Signals**: IPO completed September 2024; headcount grew 78.1% year-over-year (95 employees, though LinkedIn notes a slight monthly decline of -0.9%); operates across 8 countries including the UK, Italy, Germany, India, and Spain; 11 active job postings as of mid-2026. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)

## Competitive Advantages
- **First-in-class bifunctional approach**: By combining an EGFR-targeting antibody with a TGF-β trap, BCA101 directly addresses a key solid-tumor resistance mechanism (TGF-β-driven immunosuppression and fibrosis) while localizing therapy to the tumor.
- **Potential for superior efficacy and safety**: Designed to deliver synergistic therapeutic impact at the tumor site, aiming for deep, durable responses with reduced systemic toxicity.
- **Experienced leadership**: Team with deep oncology drug development backgrounds and relationships with top cancer centers. [bicara.com/about](https://www.bicara.com/about/)

## Strategic Focus
- **Priority**: Advancing ficerafusp alfa through clinical development toward potential regulatory approvals, initially in HPV-negative head and neck squamous cell carcinoma.
- **Pipeline expansion**: Leveraging the bifunctional antibody platform (BCA101 and follow-on programs) to address multiple solid tumor types.
- **Commercial readiness**: Hiring senior roles in medical affairs, quality, regulatory, and commercial operations signals preparation for launch. [bicara.com/careers](https://www.bicara.com/careers/)

## Why Work Here
- **Culture & Mission**: A patient-first, mission-driven environment focused on developing meaningful new therapies for cancer. Company describes itself as "dynamic" with a shared passion for advancing science. [bicara.com](https://www.bicara.com/)
- **Diversity & Inclusion**: Explicitly states commitment to building diverse teams and encourages applicants from all backgrounds. [bicara.com/careers](https://www.bicara.com/careers/)
- **Growth Trajectory**: Fast-growing public company (78% headcount growth YoY) with a strong balance sheet, offering career progression opportunities.
- **Work Environment**: Headquarters in Boston with a global presence. Specific remote/hybrid policy not publicly detailed, but the company employs staff across 8 countries. Glassdoor rating of 4.0/5 on LinkedIn based on limited reviews. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Engagement**: Active hiring across multiple senior-level roles in medical affairs, regulatory, quality, IT, and clinical operations, indicating a ramp-up toward commercialization. [bicara.com/careers](https://www.bicara.com/careers/)

## Sources
1. [bicara.com](https://www.bicara.com/) – Company home page, product, mission
2. [bicara.com/about](https://www.bicara.com/about/) – Leadership team, technology description
3. [bicara.com/careers](https://www.bicara.com/careers/) – Open positions, culture, diversity statement
4. [linkedin.com/company/bicara-therapeutics](https://www.linkedin.com/company/bicara-therapeutics) – Headcount, financials, stock info, employee reviews, talent sources
5. [massbio.org/members/bicara-therapeutics](https://www.massbio.org/members/bicara-therapeutics/) – Membership description, pipeline summary

## Other roles at Bicara Therapeutics

- [Senior Manager, GxP Audit Program Lead](https://feeny.ai/job/senior-manager-gxp-audit-program-lead-bicara-therapeutics-boston-z2743dyfw8v5) — Boston, MA
- [Director, Biostatistics](https://feeny.ai/job/director-biostatistics-bicara-therapeutics-boston-8acrty1k88h7) — Boston, MA
- [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-bicara-therapeutics-boston-308n8g5t9f73) — Boston, MA
- [Senior Medical Science Liaison - West (CA, WA)](https://feeny.ai/job/senior-medical-science-liaison-west-ca-wa-bicara-therapeutics-united-states-tv5xs4prg9y2) — United States
- [Senior Manager, Accounting and SEC Reporting](https://feeny.ai/job/senior-manager-accounting-and-sec-reporting-bicara-therapeutics-boston-hngf1v66tht9) — Boston, MA
- [Associate Director, Global Scientific Communications](https://feeny.ai/job/associate-director-global-scientific-communications-bicara-therapeutics-boston-b20sj17zmqbw) — Boston, MA
- [Sr. Quality Specialist, GxP Document Control](https://feeny.ai/job/sr-quality-specialist-gxp-document-control-bicara-therapeutics-boston-pmtejzsn39sj) — Boston, MA
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-bicara-therapeutics-boston-07s96d5xygx4) — Boston, MA
- [Associate Director, Project Management (Clinical Operations)](https://feeny.ai/job/associate-director-project-management-clinical-operations-bicara-therapeutics-jc50anna3jrm) — United States
- [Senior Director, Regulatory Affairs](https://feeny.ai/job/senior-director-regulatory-affairs-bicara-therapeutics-boston-t7b77r839mdy) — Boston, MA